StockData
Baxter International Inc logo

Baxter International Inc (BAX) stock

BAXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/304% above fair value
$25.81+0.07 (+0.27%)

Close on Nov 13, 2026Market cap $13.35BP/E –Yield 2.01%

Baxter International cash

Cash and short-term investments held at the end of each period.

Baxter International's cash was $1.98B at Sep 30, 2026. For fiscal 2025 it was $1.97B, up 11.5% from the year before. Over ten years it grew -12.4% a year on average. The highest annual figure on record is $7.36B in fiscal 2015.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.97B+11.5%
FY2024Dec 31, 2024$1.76B-42.7%
FY2023Dec 31, 2023$3.08B+89.9%
FY2022Dec 31, 2022$1.62B-45.1%
FY2021Dec 31, 2021$2.95B-21.0%
FY2020Dec 31, 2020$3.74B+12.0%
FY2019Dec 31, 2019$3.34B+81.4%
FY2018Dec 31, 2018$1.84B-46.0%
FY2017Dec 31, 2017$3.40B+22.1%
FY2016Dec 31, 2016$2.79B-62.2%
FY2015Dec 31, 2015$7.36B+151.7%
FY2014Dec 31, 2014$2.93B+7.0%
FY2013Dec 31, 2013$2.73B-16.4%
FY2012Dec 31, 2012$3.27B+12.6%
FY2011Dec 31, 2011$2.91B+8.2%
FY2010Dec 31, 2010$2.69B-3.6%
FY2009Dec 31, 2009$2.79B+30.7%
FY2008Dec 31, 2008$2.13B-16.1%
FY2007Dec 31, 2007$2.54B+2.2%
FY2006Dec 31, 2006$2.49B–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$1.98B+14.4%
Q2 FY2026Jun 30, 2026$2.15B+27.5%
Q1 FY2026Mar 31, 2026$2.02B-12.1%
Q4 FY2025Dec 31, 2025$1.97B+11.5%
Q3 FY2025Sep 30, 2025$1.73B+21.5%
Q2 FY2025Jun 30, 2025$1.69B+7.1%
Q1 FY2025Mar 31, 2025$2.29B-18.8%
Q4 FY2024Dec 31, 2024$1.76B-42.7%
Q3 FY2024Sep 30, 2024$1.42B-75.2%
Q2 FY2024Jun 30, 2024$1.57B-8.6%
Q1 FY2024Mar 31, 2024$2.83B+68.9%
Q4 FY2023Dec 31, 2023$3.08B+89.9%
Q3 FY2023Sep 30, 2023$5.72B+257.0%
Q2 FY2023Jun 30, 2023$1.72B-7.0%
Q1 FY2023Mar 31, 2023$1.67B-27.1%
Q4 FY2022Dec 31, 2022$1.62B-45.1%
Q3 FY2022Sep 30, 2022$1.60B-50.9%
Q2 FY2022Jun 30, 2022$1.85B-40.9%
Q1 FY2022Mar 31, 2022$2.29B-27.9%
Q4 FY2021Dec 31, 2021$2.95B-21.0%
Q3 FY2021Sep 30, 2021$3.26B-25.3%
Q2 FY2021Jun 30, 2021$3.14B-23.2%
Q1 FY2021Mar 31, 2021$3.18B-22.6%
Q4 FY2020Dec 31, 2020$3.74B+12.0%
Q3 FY2020Sep 30, 2020$4.36B+44.9%
Q2 FY2020Jun 30, 2020$4.09B+39.2%
Q1 FY2020Mar 31, 2020$4.11B+116.1%
Q4 FY2019Dec 31, 2019$3.34B+81.4%
Q3 FY2019Sep 30, 2019$3.01B+5.1%
Q2 FY2019Jun 30, 2019$2.93B+2.7%
Q1 FY2019Mar 31, 2019$1.90B-35.5%
Q4 FY2018Dec 31, 2018$1.84B-46.0%
Q3 FY2018Sep 30, 2018$2.86B-18.6%
Q2 FY2018Jun 30, 2018$2.86B-25.1%
Q1 FY2018Mar 31, 2018$2.95B+3.2%
Q4 FY2017Dec 31, 2017$3.40B+22.1%
Q3 FY2017Sep 30, 2017$3.52B–
Q2 FY2017Jun 30, 2017$3.82B–
Q1 FY2017Mar 31, 2017$2.86B–
Q4 FY2016Dec 31, 2016$2.79B–

More Baxter International figures

See a number that looks wrong?